Patents by Inventor Joel Desharnais

Joel Desharnais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZATION OF THROMBOCYTES AT AMBIENT TEMPERATURES
    Publication number: 20230363375
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Application
    Filed: May 26, 2023
    Publication date: November 16, 2023
    Inventors: Rolf MULLER, Joel DESHARNAIS, Steven P. WILKINSON, Victoria ARENDT, Paul DIAZ
  • Stabilization of thrombocytes at ambient temperatures
    Patent number: 11672247
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: June 13, 2023
    Assignee: Biomatrica, Inc.
    Inventors: Rolf Muller, Joel Desharnais, Steven P. Wilkinson, Victoria Arendt, Paul Diaz
  • REDUCTION OF ERYTHROCYTE SEDIMENTATION RATE
    Publication number: 20210368779
    Abstract: The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.
    Type: Application
    Filed: August 12, 2021
    Publication date: December 2, 2021
    Applicant: Biomatrica, Inc.
    Inventors: Joel Desharnais, Victoria Arendt, Margrith Mattmann
  • Reduction of erythrocyte sedimentation rate
    Patent number: 11116205
    Abstract: The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: September 14, 2021
    Assignee: BIOMATRICA, INC.
    Inventors: Joel Desharnais, Victoria Arendt, Margrith Mattmann
  • Stabilization of nucleic acids on paper
    Patent number: 11078521
    Abstract: The present invention and embodiments thereof relates to compositions and methods for storage, stabilization and preservation of biological samples and/or nucleic acids on a solid matrix. Methods for extracting, collecting, and recovering the biological samples and/or nucleic acids from the solid matrix are also described.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: August 3, 2021
    Assignee: BIOMATRICA, INC.
    Inventors: Joel Desharnais, Daniela Roth, Vasco Liberal
  • STABILIZATION OF THROMBOCYTES AT AMBIENT TEMPERATURES
    Publication number: 20200344999
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Inventors: Rolf MULLER, Joel DESHARNAIS, Steven P. WILKINSON, Victoria ARENDT, Paul DIAZ
  • REDUCTION OF ERYTHROCYTE SEDIMENTATION RATE
    Publication number: 20200300838
    Abstract: The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.
    Type: Application
    Filed: February 24, 2020
    Publication date: September 24, 2020
    Inventors: Joel Desharnais, Victoria Arendt, Margrith Mattmann
  • Stabilization of thrombocytes at ambient temperatures
    Patent number: 10772319
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: September 15, 2020
    Assignee: Biomatrica, Inc.
    Inventors: Rolf Muller, Joel Desharnais, Steven P. Wilkinson, Victoria Arendt, Paul Diaz
  • Reduction of erythrocyte sedimentation rate
    Patent number: 10568317
    Abstract: The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: February 25, 2020
    Assignee: Biomatrica, Inc.
    Inventors: Joel Desharnais, Victoria Arendt, Margrith Mattmann
  • STABILIZATION OF NUCLEIC ACIDS ON PAPER
    Publication number: 20190264257
    Abstract: The present invention and embodiments thereof relates to compositions and methods for storage, stabilization and preservation of biological samples and/or nucleic acids on a solid matrix. Methods for extracting, collecting, and recovering the biological samples and/or nucleic acids from the solid matrix are also described.
    Type: Application
    Filed: October 24, 2017
    Publication date: August 29, 2019
    Inventors: Joel Desharnais, Daniela Roth, Vasco Liberal
  • STABILIZATION OF PCR REAGENTS AND ASSAYS
    Publication number: 20180363026
    Abstract: The present invention relates to stabilization of one or more component of a PCR or RT-PCR reaction mixture at ambient temperatures. In particular, formulations, compositions, articles of manufacture, kits and methods for substantially stable storage of one or more component of a PCR or RT-PCR reaction mixture at ambient temperatures are provided.
    Type: Application
    Filed: December 6, 2016
    Publication date: December 20, 2018
    Inventors: Joel DESHARNAIS, Colin POWERS
  • REDUCTION OF ERYTHROCYTE SEDIMENTATION RATE
    Publication number: 20180352806
    Abstract: The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.
    Type: Application
    Filed: December 6, 2016
    Publication date: December 13, 2018
    Inventors: Joel DESHARNAIS, Victoria ARENDT, Margrith MATTMANN
  • STABILIZATION OF THROMBOCYTES AT AMBIENT TEMPERATURES
    Publication number: 20180332841
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 22, 2018
    Inventors: Rolf MULLER, Joel DESHARNAIS, Steven P. WILKINSON, Victoria ARENDT, Paul DIAZ
  • Stabilization of thrombocytes at ambient temperatures
    Patent number: 10064404
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: September 4, 2018
    Assignee: BIOMATRICA, INC.
    Inventors: Rolf Muller, Joel Desharnais, Steven P. Wilkinson, Victoria Arendt, Paul Diaz
  • STABILIZATION OF THROMBOCYTES AT AMBIENT TEMPERATURES
    Publication number: 20170196220
    Abstract: Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures. Further provided are articles of manufacture and kits and methods for substantially stable storage of one or more thrombocyte at ambient temperatures.
    Type: Application
    Filed: June 9, 2015
    Publication date: July 13, 2017
    Inventors: Rolf MULLER, Joel DESHARNAIS, Steven P. WILKINSON, Victoria ARENDT, Paul DIAZ
  • Anti-angiogenic compounds
    Patent number: 8937048
    Abstract: The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: January 20, 2015
    Assignee: Covx Technologies Ireland, Limited
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • ANTI-ANGIOGENIC COMPOUNDS
    Publication number: 20120321591
    Abstract: The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • Anti-angiogenic compounds
    Patent number: 8293714
    Abstract: The present invention provides VEGF binding peptides. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules. Various uses of the peptides and compounds are provided, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Grant
    Filed: April 29, 2009
    Date of Patent: October 23, 2012
    Assignee: Covx Technology Ireland, Ltd.
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • C-10 carbamates of taxanes
    Patent number: 8138361
    Abstract: Provided herein are C-10 taxane carbamates and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating cancer and taupathy.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: March 20, 2012
    Assignees: The Trustees Of The University Of Pennsylvania, Acidophil, LLC
    Inventors: Carlo Ballatore, Angelo J Castellino, Amos B Smith, III, Joel Desharnais, Chengzao Sun, Simon E Aspland
  • ANTI-ANGIOGENIC COMPOUNDS
    Publication number: 20100003267
    Abstract: The present invention provides VEGF binding peptides. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules. Various uses of the peptides and compounds are provided, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Application
    Filed: April 29, 2009
    Publication date: January 7, 2010
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw